Registry Study of Chinese Patients with Marginal Zone Lymphoma (MOTIVE)

NCT06534463 · clinicaltrials.gov ↗

RECRUITING

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Marginal Zone Lymphoma

Interventions

OTHER: All treatment regimen selections and usage will be determined by the physician based on clinical practice and/or the respective drug labels in China.

Sponsor

Ruijin Hospital